ScreenerHero
SBRASabra Health Care REIT, Inc.
NAS · US · Real Estate · REIT - Healthcare Facilities · sabrahealth.com
19.62USD-1.31%Mkt Cap: 4.95B $P/E: 31.14

Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the Unite…

Industry Peers

REIT - Healthcare Facilities
Screen all
WELL
Welltower Inc.
$163.48BUSDP/E 111.9
VTR
Ventas, Inc.
$44.08BUSDP/E 164.8
OHI
Omega Healthcare Investors, Inc.
$15.06BUSDP/E 23.3
DOC
Healthpeak Properties, Inc.
$14.93BUSDP/E 67.7
CTRE
CareTrust REIT, Inc.
$9.50BUSDP/E 25.5
HR
Healthcare Realty Trust Incorporated
$7.26BUSD
AED
Aedifica NV/SA
$6.28BUSDP/E 6.0
CSH-UN
Chartwell Retirement Residences
$5.46BUSDP/E Infinity
NHI
National Health Investors, Inc.
$3.65BUSDP/E 24.3
COFB
Cofinimmo SA
$3.43BUSDP/E 15.5
PHP
Primary Health Properties Plc
$2.63BUSDP/E 13.3
MPT
Medical Properties Trust, Inc.
$2.70BUSD
DHC
Diversified Healthcare Trust
$2.12BUSD
LTC
LTC Properties, Inc.
$1.99BUSDP/E 15.2
SILA
Sila Realty Trust Inc
$1.68BUSDP/E 44.6
NHP
National Healthcare Properties, Inc.
$1.11BUSD
CPINV
Care Property Invest NV
$578.96MUSDP/E 8.3
UHT
Universal Health Realty Income Trust
$597.48MUSDP/E 33.6
XRN
Chiron Real Estate Inc.
$570.92MUSD
CHCT
Community Healthcare Trust Incorporated
$514.58MUSDP/E 150.1
STRW
Strawberry Fields REIT, Inc.
$183.27MUSDP/E 21.3
Indicators:|

Key Statistics

Company
Market Cap4.95B $
Enterprise Value7.56B $
Revenue (TTM)815.66M $
Gross Profit503.53M $
Net Income (TTM)155.61M $
Revenue/Share3.331 USD
Last Price19.62 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees58
CountryUS
SectorReal Estate
IndustryREIT - Healthcare Facilities
ISINUS78573L1061
Valuation
P/E (Trailing)31.14
P/E (Forward)26.74
PEG5.28
EV/EBITDA16.47
EV/Revenue9.27
P/S6.15
P/B1.80
EPS (TTM)0.63
EPS (Forward)0.74
52W Range
17.1760% of range21.28
52W High21.28 USD
52W Low17.17 USD
Profitability
Gross Margin65.00%
Oper. Margin31.41%
EBITDA Margin56.30%
Profit Margin20.09%
ROE5.51%
ROA2.83%
Growth
Revenue Growth21.70%
Earnings Growth-5.60%
Cash Flow & Leverage
Operating CF348.61M $
CapEx (TTM)—
FCF Margin24.25%
FCF Yield4.00%
Net Debt2.55B $
Net Debt/EBITDA5.55
Balance Sheet
Debt/Equity0.90
Current Ratio2.62
Quick Ratio1.99
Book Value/Sh11.05 USD
Cash/Share0.4920 USD
Dividends
Fwd Div Rate1.200 USD
Trail. Div Rate1.200 USD
Div. Yield5.99%
5Y Avg Yield7.93%
Payout Ratio190.48%
Ex-Div DateMay 15, 2026
Pay DateMay 29, 2026
Splits
Last Split1:3
Split DateNov 16, 2010
Analyst Consensus
Rating2.5 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)22.07 USD
Upside (mean)+12.5%
Target Range19.00 USD – 25.00 USD
$19.00+12.5% to mean$25.00
# Analysts14
Ownership
Shares Out.252.19M
Float247.96M
Insiders1.41%
Institutions107.12%
Short Interest
Short Ratio9.4d
Short % Float14.50%
Short % Out.10.53%
Shares Short26.55M
Short (prev mo.)31.37M
Technical
SMA 5019.73 (-0.6%)
SMA 20019.34 (+1.5%)
Beta0.63
S&P 52W Chg20.11%
Avg Vol (30d)2.92M
Avg Vol (10d)3.51M
Technical Indicators
RSI (14)52.8
MACD0.1303
MACD Signal-0.0156
MACD Hist.+0.1459
BB Upper20.44 USD
BB Middle19.12 USD
BB Lower17.79 USD
BB Width13.88%
ATR (14)0.4929 USD
Vol Ratio (20d)0.69x